1)日本臨床腫瘍学会(編).骨転移診療ガイドライン.改訂第2版.東京:南江堂;2022.
2)Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer:a randomised trial. Lancet 2005;366(9486):643-8.
3)Kakutani K, Sakai Y, Zhang Z, et al. Survival rate after palliative surgery alone for symptomatic spinal metastases:a prospective cohort study. J Clin Med 2022;11(21):6227. doi:10.3390/jcm11216227.
4)Meyer M, Farah K, Aurélie T, et al. Management of spinal metastasis by minimally invasive surgical techniques:surgical principles and indications- a literature review. J Clin Med 2023;12(16):5165. doi:10.3390/jcm12165165.
5)和佐潤志,片桐浩久.予後予測を踏まえた脊椎転移の診療.髙木辰哉(編).脊椎転移パーフェクト診療—がんロコモを防ぐために.東京:南江堂;2020.p.100-5.
6)Tokuhashi Y, Uei H, Oshima M. Classification and scoring systems for metastatic spine tumors:a literature review. Spine Surg Relat Res 2017;1(2):44-55.
7)Quraishi NA, Rajagopal TS, Manoharan SR, et al. Effect of timing of surgery on neurological outcome and survival in metastatic spinal cord compression. Eur Spine J 2013;22(6):1383-8.
8)Chi JH, Gokaslan Z, McCormick P, et al. Selecting treatment for patients with malignant epidural spinal cord compression-does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976) 2009;34(5):431-5.
9)Kanda Y, Kakutani K, Sakai Y, et al. Clinical characteristics and surgical outcomes of metastatic spine tumors in the very elderly:a prospective cohort study in a super-aged society. J Clin Med 2023;12(14):4747. doi:10.3390/jcm12144747.
10)Fisher CG, Dipaola CP, Ryken TC, et al. A novel classification system for spinal instability in neoplastic disease:an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine 2010;35(22):E1221-9. doi:10.1097/BRS.0b013e3181e16ae2.
11)Laufer I, Iorgulescu JB, Chapman T, et al. Local disease control for spinal metastases following “separation surgery” and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery:outcome analysis in 186 patients. J Neurosurg Spine 2013;18(3):207-14.
12)Kobayashi T, Arai Y, Takeuchi Y, et al. Phase I/II clinical study of percutaneous vertebroplasty (PVP) as palliation for painful malignant vertebral compression fractures (PMVCF):JIVROSG-0202. Ann Oncol 2009;20(12):1943-7.
13)Chew C, Craig L, Edwards R, et al. Safety and efficacy of percutaneous vertebroplasty in malignancy:a systematic review. Clin Radiol 2011;66(1):63-72.
14)Bouza C, López-Cuadrado T, Cediel P, et al. Balloon kyphoplasty in malignant spinal fractures:a systematic review and meta-analysis. BMC Palliat Care 2009;8:12. doi:10.1186/1472-684X-8-12.
15)Wang L, Zhang C, Liang H, et al. Cement leakage in percutaneous vertebroplasty for spinal metastases:a retrospective study of risk factors and clinical outcomes. World J Surg Oncol 2022;20(1):112. doi:10.1186/s12957-022-02583-5.
16)Rades D, Huttenlocher S, Bajrovic A, et al. Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors. Int J Radiat Oncol Biol Phys 2011;81(5):e861-8. doi:10.1016/j.ijrobp.2010.11.056.
17)Tarawneh AM, Pasku D, Quraishi NA. Surgical complications and re-operation rates in spinal metastases surgery:a systematic review. Eur Spine J 2021;30(10):2791-9.
18)Bernstein EF, Harisiadis L, Salomon GD, et al. Healing impairment of open wounds by skin irradiation. J Dermatol Surg Oncol 1994;20(11):757-60.
19)Itshayek E, Yamada J, Bilsky M, et al. Timing of surgery and radiotherapy in the management of metastatic spine disease:a systematic review. Int J Oncol 2010;36(3):533-44.
20)Kumar N, Madhu S, Bohra H, et al. Is there an optimal timing between radiotherapy and surgery to reduce wound complications in metastatic spine disease? A systematic review. Eur Spine J 2020;29(12):3080-115.